Launch week offerEnds in00h00m00s

annual Promonthly Pro

Peter Alter

Prof, MD, FESC

University of Marburg

Germany

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Germany

Articles (18)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (7)

Klaus F. Rabe

Professor of Pulmonary Medicine

Christian-Albrechts-Universität zu Kiel

GERMANY

View details

Michael Pienn

AUSTRIA

View details

Felipe V C Machado

Doctor assistant in Rehabilitation Sciences and Physiotherapy

Hasselt University

BELGIUM

View details

Franziska Trudzinski

Heidelberg University

GERMANY

View details

Rolf Holle

Helmholtz Zentrum München Deutsches Forschungszentrum für Umwelt und Gesundheit

GERMANY

View details

Anna Lena Jung

Akademische Rätin / Group Leader (tenured)

Philipps-Universität Marburg

GERMANY

View details

Stefan Andreas

Head

Lungenfachklinik Immenhausen

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Peter Alter

Research Interests

Make your next move.

Explore related searches

Articles (18)

Analysis of change in health-related quality of life in patients with COPD over 6 years, including information on dropouts: Results from the German COSYCONET cohort

Association of Obesity with Symptoms and Quality of Life in COPD: Results from COSYCONET

Relationship Between the Levels of Feno, Blood Eosinophils, and the Severity of Exacerbations in Patients With COPD

Diffusion capacity and static hyperinflation as markers of disease progression predict 3‐year mortality in COPD: Results from COSYCONET

Characterization and Mortality Risk of Impaired Left Ventricular Filling in COPD

Expiratory Venous Volume and Arterial Tortuosity are Associated with Disease Severity and Mortality Risk in Patients with COPD: Results from COSYCONET

Differential Impact of Low Fat-Free Mass in People With COPD Based on BMI Classifications

Characteristics of Current Smokers versus Former Smokers with COPD and Their Associations with Smoking Cessation Within 4.5 Years: Results from COSYCONET

Clinical factors linked to the type of respiratory medication in COPD: results from the COSYCONET cohort

Disease Progression and Age as Factors Underlying Multimorbidity in Patients with COPD: Results from COSYCONET

A new approach for the detection of obesity-related airway obstruction in lung-healthy individuals

Basic Determinants of Disease Knowledge in COPD Patients: Results from COSYCONET

Differences in the Measurement of Functional Residual Capacity Between Body Plethysmographs of Two Manufacturers

Impact of the COVID-19 pandemic on the behaviour and health status of patients with COPD: results from the German COPD cohort COSYCONET

Treatment of COPD Groups GOLD A and B with Inhaled Corticosteroids in the COSYCONET Cohort – Determinants and Consequences

<p>Impact of Education on COPD Severity and All-Cause Mortality in Lifetime Never-Smokers and Longtime Ex-Smokers: Results of the COSYCONET Cohort</p>

Update in Chronic Obstructive Pulmonary Disease 2019

<p>A Post Hoc Holter ECG Analysis of Olodaterol and Formoterol in Moderate-to-Very-Severe COPD</p>

Collaborators (7)

Klaus F. Rabe

Michael Pienn

Felipe V C Machado

Franziska Trudzinski

Rolf Holle

Anna Lena Jung

Stefan Andreas

Make your next move.